Pharis Mohideen
CIK 1760395 · Chief Medical Officer · last filed 2026-02-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.53M
Companies
2
Total Filings
15
Lifetime Open-Market Net
-$43.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DBVT | Chief Medical Officer | 144,995 | $17.41 | $2.53M | -$43.7K | 13 | 2026-02-02 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Medical Officer | 7,440 | $15.90 | $118.3K | $0 | 2 | 2019-01-17 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-22 | DBVT | Grant (A) | +35,000 | $0 | EDGAR |
| 2023-08-14 | DBVT | Mixed | +25,239 | -$6.8K | EDGAR |
| 2021-11-24 | DBVT | Grant (A) | +8,700 | $0 | EDGAR |
| 2019-01-17 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-11 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | +7,440 | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.